E-LIB Suche - Ergebnisse für: Budha, N.

1

Impact of Physiologically Based Pharmacokinetic Models on R..:

Yoshida, K ; Budha, N ; Jin, JY
Clinical Pharmacology & Therapeutics. 101 (2017) 5 - p. 597-602 , 2017

Link: https://doi.org/10.1002/..

2

A Mechanistic Systems Pharmacology Model for Prediction of ..:

Gadkar, K ; Budha, N ; Baruch, A...
CPT: Pharmacometrics & Systems Pharmacology. 3 (2014) 11 - p. 1-9 , 2014

Link: https://doi.org/10.1038/..

3

Effects of RG7652, a fully human mAb against proprotein con..:

Tingley, W. ; Luca, D. ; Leabman, M....
European Heart Journal. 34 (2013) suppl 1 - p. P4183-P4183 , 2013

Link: https://doi.org/10.1093/..

4

611 Assessment of CYP3A Inhibition, Food Effect, and Glucos..:

Musib, L. ; Budha, N. ; Funke, R....
European Journal of Cancer. 48 (2012) - p. 188 , 2012

Link: https://doi.org/10.1016/..

5

393 Phase I pharmacokinetics and pharmacodynamics of GDC-01..:

Fairbrother, W. ; LoRusso, P. ; Wagner, A....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 125 , 2010

Link: https://doi.org/10.1016/..

6

82 Pharmacokinetic–pharmacodynamic modeling of the effect o..:

Fairbrother, W. ; Wong, H. ; Budha, N....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 34 , 2010

Link: https://doi.org/10.1016/..

7

Drug Absorption Interactions Between Oral Targeted Anticanc..:

Budha, N R ; Frymoyer, A ; Smelick, G S...
Clinical Pharmacology & Therapeutics. 92 (2012) 2 - p. 203-213 , 2012

Link: https://doi.org/10.1038/..

8

Response to "Drug Interactions Produced by Proton Pump Inhi..:

Budha, N R ; Benet, L Z ; Ware, J A
Clinical Pharmacology & Therapeutics. 93 (2012) 2 - p. 151-151 , 2012

Link: https://doi.org/10.1038/..

9

A microbiological assessment of novel nitrofuranylamides as..:

Hurdle, J. G. ; Lee, R. B. ; Budha, N. R....
Journal of Antimicrobial Chemotherapy. 62 (2008) 5 - p. 1037-1045 , 2008

Link: https://doi.org/10.1093/..

10

Impact of Physiologically Based Pharmacokinetic Models on R..:

Yoshida, K ; Budha, N ; Jin, JY
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414891/. , 2017

Link: http://www.ncbi.nlm.nih...

11

A Mechanistic Systems Pharmacology Model for Prediction of ..:

Gadkar, K ; Budha, N ; Baruch, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

12

A Mechanistic Systems Pharmacology Model for Prediction of ..:

K Gadkar ; N Budha ; A Baruch...
https://doi.org/10.1038/psp.2014.47. , 2014

Link: https://doi.org/10.1038/..

13

Program Kerjasama Perkumpulan Tenaga Ahli Alat Berat Indone..:

Puji Saksono ; Gunawan ; Budha Maryanti..
Abdimas Awang Long. 7 (2024) 2 - p. 174-179 , 2024

Link: https://doi.org/10.56301..

14

Considerations for Industry—Preparing for the FDA Model‐Inf..:

Galluppi, Gerald R. ; Ahamadi, Malidi ; Bhattacharya, Souvik...
Clinical Pharmacology & Therapeutics. 116 (2024) 2 - p. 282-288 , 2024

Link: https://doi.org/10.1002/..

15

Prevalence of Acid-Reducing Agents (ARA) in Cancer Populati..:

Smelick, Gillian S. ; Heffron, Timothy P. ; Chu, Laura...
Molecular Pharmaceutics. 10 (2013) 11 - p. 4055-4062 , 2013

Link: https://doi.org/10.1021/..